Eli Lilly Balance Sheet Health
Financial Health criteria checks 3/6
Eli Lilly has a total shareholder equity of $12.9B and total debt of $26.3B, which brings its debt-to-equity ratio to 204.3%. Its total assets and total liabilities are $63.9B and $51.0B respectively. Eli Lilly's EBIT is $11.8B making its interest coverage ratio 31.3. It has cash and short-term investments of $2.7B.
Key information
204.3%
Debt to equity ratio
US$26.35b
Debt
Interest coverage ratio | 31.3x |
Cash | US$2.65b |
Equity | US$12.90b |
Total liabilities | US$51.05b |
Total assets | US$63.94b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LLY's short term assets ($25.2B) exceed its short term liabilities ($18.6B).
Long Term Liabilities: LLY's short term assets ($25.2B) do not cover its long term liabilities ($32.4B).
Debt to Equity History and Analysis
Debt Level: LLY's net debt to equity ratio (183.7%) is considered high.
Reducing Debt: LLY's debt to equity ratio has reduced from 624% to 204.3% over the past 5 years.
Debt Coverage: LLY's debt is not well covered by operating cash flow (14%).
Interest Coverage: LLY's interest payments on its debt are well covered by EBIT (31.3x coverage).